Free Trial

Greg Harrison Analyst Performance

Analyst at Bank of America

Greg Harrison is a stock analyst at Bank of America, covering 16 publicly traded companies across a range of sectors. Over the past year, Greg Harrison has issued 28 stock ratings, including buy and hold recommendations. While full access to Greg Harrison's proprietary MarketBeat Analyst Rating is reserved for MarketBeat All Access subscribers, the rating is updated daily to reflect the most recent analyst activity. This profile highlights Greg Harrison's coverage history, rating activity, and performance tendencies — helping individual investors make more informed trading decisions.

Analyst Ratings, Coverage, and Performance Statistics

Average Return
00.00% 12-Month ROI
Success Rate
00.00% Profitable Ratings
Total Ratings
28 Last 0 Years
Buy Recommendations
71.43% 20 Buy Ratings
Companies Covered
16 Unique Companies

Ratings Distribution

RatingPercentageCount
Strong Buy0.0%0 ratings
Buy71.4%20 ratings
Hold28.6%8 ratings
Sell0.0%0 ratings

Out of 28 total stock ratings issued by Greg Harrison at Bank of America, the majority (71.4%) have been Buy recommendations, followed by 28.6% Hold.

Best & Worst Calls

This analyst does not have any ratings with enough history to determine best and worst calls.

Exchange Coverage

ExchangePercentageCount
NASDAQ
100.0% of companies on NASDAQ
16 companies

Greg Harrison, an analyst at Bank of America, currently covers 16 companies listed on , with the majority traded on NASDAQ.

Coverage Focus

Sector IconSectorPercentage
Medical
16 companies
100.0%

Greg Harrison of Bank of America specializes in stock coverage within the Medical sector.

Coverage Industries

IndustryPercentage
MED - BIOMED/GENE
13 companies
81.3%
MED - DRUGS
2 companies
12.5%
MED - GENERIC DRG
1 company
6.3%

Greg Harrison's Ratings History at Bank of America

Recommendation ROI is the percentage between the price on the Report Date to the price 12 months after the report date.
Available with a MarketBeat All Access Subscription
12-Month ROIUpgrade to All Access to use the All ROI Filter
CompanyReport DateActionReport Date Price12-Month
Price Target
Rating12-Month
Price & ROI
Details
United Therapeutics Corporation stock logo
UTHR
United Therapeutics
9/2/2025Boost Price Target$409.21$463.00Neutral
Mineralys Therapeutics, Inc. stock logo
MLYS
Mineralys Therapeutics
8/28/2025Boost Price Target$15.29$43.00Buy
Rocket Pharmaceuticals, Inc. stock logo
RCKT
Rocket Pharmaceuticals
8/20/2025Upgrade$3.66$10.00Buy
Travere Therapeutics, Inc. stock logo
TVTX
Travere Therapeutics
8/7/2025Boost Price Target$16.79$31.00Sector Outperform
Ocular Therapeutix, Inc. stock logo
OCUL
Ocular Therapeutix
8/6/2025Lower Price Target$12.35$20.00Sector Outperform
BridgeBio Pharma, Inc. stock logo
BBIO
BridgeBio Pharma
8/6/2025Boost Price Target$43.74$57.00Sector Outperform
Vertex Pharmaceuticals Incorporated stock logo
VRTX
Vertex Pharmaceuticals
8/5/2025Lower Price Target$392.94$438.00Sector Perform
Alnylam Pharmaceuticals, Inc. stock logo
ALNY
Alnylam Pharmaceuticals
8/1/2025Boost Price Target$401.80$450.00Sector Outperform
Agios Pharmaceuticals, Inc. stock logo
AGIO
Agios Pharmaceuticals
7/28/2025Lower Price Target$37.20$65.00Sector Outperform
Rocket Pharmaceuticals, Inc. stock logo
RCKT
Rocket Pharmaceuticals
7/25/2025Reiterated Rating$3.21$4.00Neutral
Agios Pharmaceuticals, Inc. stock logo
AGIO
Agios Pharmaceuticals
7/22/2025Lower Price Target$39.54$51.00Buy
Gossamer Bio, Inc. stock logo
GOSS
Gossamer Bio
7/14/2025Initiated Coverage$1.36$11.00Sector Outperform
United Therapeutics Corporation stock logo
UTHR
United Therapeutics
6/11/2025Lower Price Target$278.95$315.00Neutral
Vera Therapeutics, Inc. stock logo
VERA
Vera Therapeutics
6/2/2025Set Price Target$30.98$65.00Sector Outperform
Arcturus Therapeutics Holdings Inc. stock logo
ARCT
Arcturus Therapeutics
5/28/2025Initiated Coverage$11.87$32.00Sector Outperform
Rocket Pharmaceuticals, Inc. stock logo
RCKT
Rocket Pharmaceuticals
5/28/2025Lower Price Target$2.41$19.00Sector Outperform
Liquidia Technologies, Inc. stock logo
LQDA
Liquidia Technologies
5/28/2025Boost Price Target$14.70$37.00Sector Outperform
Rocket Pharmaceuticals, Inc. stock logo
RCKT
Rocket Pharmaceuticals
5/28/2025Lower Price Target$2.51$9.00Buy
Rocket Pharmaceuticals, Inc. stock logo
RCKT
Rocket Pharmaceuticals
5/12/2025Lower Price Target$7.16$51.00Sector Outperform
Keros Therapeutics, Inc. stock logo
KROS
Keros Therapeutics
5/12/2025Lower Price Target$13.52$26.00Sector Outperform
Geron Corporation stock logo
GERN
Geron
5/8/2025Downgrade$1.31$1.50Sector Perform
Apellis Pharmaceuticals, Inc. stock logo
APLS
Apellis Pharmaceuticals
5/8/2025Lower Price Target$17.49$20.00Sector Perform
Vertex Pharmaceuticals Incorporated stock logo
VRTX
Vertex Pharmaceuticals
5/6/2025Lower Price Target$434.64$442.00Sector Perform
Liquidia Technologies, Inc. stock logo
LQDA
Liquidia Technologies
5/5/2025Boost Price Target$16.30$36.00Sector Outperform
Agios Pharmaceuticals, Inc. stock logo
AGIO
Agios Pharmaceuticals
5/2/2025Lower Price Target$31.18$71.00Sector Outperform
BridgeBio Pharma, Inc. stock logo
BBIO
BridgeBio Pharma
4/30/2025Boost Price Target$38.50$55.00Sector Outperform
United Therapeutics Corporation stock logo
UTHR
United Therapeutics
4/21/2025Upgrade$284.73$314.00Neutral
Travere Therapeutics, Inc. stock logo
TVTX
Travere Therapeutics
4/1/2025Boost Price Target$17.92$31.00Buy